Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets

Simply Wall St.

Mar 17

Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2620324476"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620324476\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620324476?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","is_english":true,"pubTime":"2026-03-17 22:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620324476","market":"sg","top_or_hot":-1,"title":"Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets","media":"Simply Wall St.","content":"<div>\n<p>Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAshland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-17 22:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2463526074.USD","symbol_name":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det","article_id":"2620324476","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620324476","pubTimestamp":1773756960,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million of expected FY2026 savings from a broader US$90 million manufacturing optimization program.\nDespite headwinds from a facility outage and asbestos litigation reserves, Ashland emphasized a strong balance sheet and plans for double-digit-plus adjusted EPS growth, underscoring how cost initiatives...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","ASH.AU":"ASHLEY SERVICES GROUP LTD","BK7057":"人力资源与就业服务","ASH":"Ashland","BK4109":"特种化学制品"},"translate_title":"亚什兰(ASH)在收紧2026年前景并详细说明新的成本节约目标后下跌7.7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASH":1.5,"ASH.AU":1.5},"content_text":"Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million of expected FY2026 savings from a broader US$90 million manufacturing optimization program. Despite headwinds from a facility outage and asbestos litigation reserves, Ashland emphasized a strong balance sheet and plans for double-digit-plus adjusted EPS growth, underscoring how cost initiatives and portfolio mix are supporting profitability. We will now examine how Ashland’s manufacturing optimization-driven cost savings reshape its investment narrative and longer-term earnings profile. Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.AdvertisementAshland Investment Narrative RecapTo own Ashland, you need to believe its shift toward higher value Life Sciences and Personal Care, combined with disciplined cost control, can offset recent earnings volatility and sector skepticism. The latest update on manufacturing optimization and FY2026 adjusted EBITDA of US$400 million–US$420 million supports the near term margin improvement catalyst, while asbestos litigation reserves and operational disruptions remain the most immediate risks. Overall, the news appears supportive rather than transformative for the core thesis. The most relevant recent announcement here is Ashland’s manufacturing network optimization, which underpins the roughly US$30 million in expected FY2026 savings out of a US$90 million program. Those savings tie directly into the company’s push for higher EBITDA and adjusted EPS growth, reinforcing the idea that cost actions and portfolio mix, rather than top line acceleration, are doing much of the work behind near term earnings improvement. Yet beneath Ashland’s cost progress, investors should still pay close attention to asbestos litigation exposures and what they may mean for... Read the full narrative on Ashland (it's free!)Ashland's narrative projects $2.0 billion revenue and $347.1 million earnings by 2028.Uncover how Ashland's forecasts yield a $67.10 fair value, a 32% upside to its current price.Exploring Other PerspectivesASH 1-Year Stock Price Chart Some of the most optimistic analysts were already banking on Ashland reaching about US$2.1 billion in revenue and US$339.0 million in earnings by 2028, so this new cost savings update could either reinforce or challenge that upbeat view, especially when you weigh it against the risk that tighter environmental rules might still pressure parts of the traditional portfolio.Explore another fair value estimate on Ashland - why the stock might be worth as much as 32% more than the current price!The Verdict Is YoursDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Ashland research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free Ashland research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ashland's overall financial health at a glance.Curious About Other Options?Opportunities like this don't last. These are today's most promising picks. Check them out now:AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.Find 47 companies with promising cash flow potential yet trading below their fair value.The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}